Orthofix Medical Inc.
Organization details
- Legal name
- Orthofix Medical Inc.
- Former names
- Orthofix International N V
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Headquarters city
- Lewisville
- Headquarters state / province
- Texas
- Headquarters country
- Curacao
- Fiscal year end
- December
- Ticker symbol
- OFIX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000884624
Board of directors
-
Alan Lee Bazaar · DirectorSince 2023
-
Catherine M. Burzik · Director · Interim CEOSince 2023
-
Charles R. Kummeth · DirectorSince 2023
-
James F. Hinrichs · DirectorSince 2023
-
Jason Hannon · DirectorSince 2023
-
John B. Henneman III · DirectorSince 2023
-
Jon Carl Serbousek · Director · Executive ChairmanSince 2023
-
Keith Valentine · Director · President & CEOSince 2023
-
Lilly Marks · DirectorSince 2023
-
Massimo Calafiore · Director · President & CEOSince 2024
-
Michael E. Paolucci · DirectorSince 2023
-
Michael Finegan · DirectorSince 2023
-
Shweta Maniar · DirectorSince 2023
-
Stuart Essig · DirectorSince 2023
-
Thomas A. West · DirectorSince 2023
-
Vickie L. Capps · DirectorSince 2025
-
Wayne Burris · DirectorSince 2023
Chief executives
Solid · grade C
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 62
5% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
62.1% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2023.
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.2%
-
82.8%
-
95.8%
-
96.4%
-
96.6%
-
97.3%
-
97.6%
-
97.8%
-
97.8%
-
98.6%
Board connections
10 of this board's directors also sit on 19 other boards. 15 are in the same sector.
-
SI-BONE Inc. Same sectorvia Keith Valentine and Thomas A. West
-
Alphatec Holdings Inc. Same sectorvia Keith Valentine
-
Anika Therapeutics Inc. Same sectorvia John B. Henneman III
-
Aprea Therapeutics Inc. Same sectorvia John B. Henneman III
-
Becton Dickinson and Company Same sectorvia Catherine M. Burzik
-
Bio-Techne Corp Same sectorvia Charles R. Kummeth
-
CeriBell Inc. Same sectorvia Thomas A. West
- via Alan Lee Bazaar
- via Charles R. Kummeth
-
IDEXX Laboratories Inc. Same sectorvia Stuart Essig
-
Inogen Inc Same sectorvia Thomas A. West
-
Integer Holdings Corporation Same sectorvia James F. Hinrichs
-
Integra LifeSciences Holdings Corporation Same sectorvia Stuart Essig
-
Janux Therapeutics Inc. Same sectorvia Vickie L. Capps
-
Outset Medical Inc. Same sectorvia James F. Hinrichs
- via Stuart Essig
- via Charles R. Kummeth
-
Regentis Biomaterials Ltd. Same sectorvia Keith Valentine
-
RxSight Inc. Same sectorvia Shweta Maniar
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $4,091,867
- 16 purchases by 4 insiders
- Sold, last 12 months
- $6,606,477
- 29 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Fisher Patrick Officer (President, Global Limb Recon) | Open-market sale | −150 | $9.07 | $1,361 |
| Oct 1, 2026 | Fisher Patrick Officer (President, Global Limb Recon) | Open-market sale | −150 | $9.44 | $1,416 |
| Sep 21, 2026 | Juniper Investment Company, LLC 10% owner | Open-market sale | +190,000 | $8.86 | $1,683,400 |
| Sep 18, 2026 | Juniper Investment Company, LLC 10% owner | Open-market sale | +120,000 | $8.74 | $1,048,800 |
| Sep 1, 2026 | Fisher Patrick Officer (President, Global Limb Recon) | Open-market sale | −150 | $9.39 | $1,409 |
| Aug 18, 2026 | Fisher Patrick Officer (President, Global Limb Recon) | Open-market sale | −1,295 | $10.09 | $13,067 |
| Aug 17, 2026 | Alexis P. Michas 10% owner | Open-market sale | +20,000 | $10.01 | $200,200 |
| Aug 14, 2026 | Alexis P. Michas 10% owner | Open-market sale | +19,500 | $10.38 | $202,410 |
| Jun 18, 2026 | McPherron Aviva Officer (Pres, Global Ops & Qual) | Open-market sale | −3,670 | $9.38 | $34,425 |
| Jun 10, 2026 | Alan Lee Bazaar Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | Charles R. Kummeth Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | Jason Hannon Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | Michael Finegan Director | Grant or award | +20,721 | — | — |
| Jun 10, 2026 | Vickie L. Capps Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | John B. Henneman III Director | Grant or award | +14,965 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Orthofix Medical Inc.
Who is the CEO of Orthofix Medical Inc.?
Massimo Calafiore has been Orthofix Medical Inc.'s President & CEO since January 2024.
How many directors are on Orthofix Medical Inc.'s board?
Orthofix Medical Inc.'s board has 17 directors: Alan Lee Bazaar, Catherine M. Burzik, Charles R. Kummeth, James F. Hinrichs, Jason Hannon, John B. Henneman III, Jon Carl Serbousek, Keith Valentine, Lilly Marks, Massimo Calafiore and 7 others.
Are Orthofix Medical Inc. insiders buying or selling shares?
Over the last 12 months, Orthofix Medical Inc. insiders bought $4.1 million of shares in 16 purchases and sold $6.6 million of shares in 29 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="orthofix-medical-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.